Phapros Tbk. vs Singaraja Putra Tbk. — how do they compare? Phapros Tbk. trades at Rp298 (market cap 250.32B, 116.6K 24h volume), while Singaraja Putra Tbk. trades at Rp13,100 (market cap 16.29T, 13.16M 24h volume). The key difference: Singaraja Putra Tbk. is far larger — about 65.1× Phapros Tbk.'s market cap, and Singaraja Putra Tbk. is more actively traded (13.16M versus 116.6K). Which is the better fit depends on your goals.
| PEHA | SINI | |
|---|---|---|
Market Cap | 250.32B | 16.29T |
Volume | 116.6K | 13.16M |
Lot | 1.17K | 131.6K |
Turnover | 34.22M | 174.44B |
Average Price | 293.45 | 13,255.29 |
Value | 34.22M | 174.44B |
Indicative Equilibrium Price | 300 | 13,100 |
Indicative Equilibrium Volume | 7 | 2.97K |
Trailing returns across standard periods
Latest headlines on both assets
PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →PT Singaraja Putra Tbk (the Company) was established based on Notarial Deed No. 52 dated November 23, 2005 of Notary Sri Herawati Anwar Effendi, S.H. The Company commenced commercialoperations in 2006.
Read more on SINI →